Aztreonam for Inhalation (AI) in Patients With Cystic Fibrosis & P. Aeruginosa Infection
Public ClinicalTrials.gov record NCT01055847. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Blinded, Multicenter, Randomized, Placebo-Controlled Trial With Aztreonam for Inhalation (AI) in Cystic Fibrosis Patient With Lung Disease Due to P. Aeruginosa Infection
Study identification
- NCT ID
- NCT01055847
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Gilead Sciences
- Industry
- Enrollment
- 105 participants
Conditions and interventions
Conditions
Interventions
- Aztreonam for Inhalation (AI) Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 13 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2003
- Primary completion
- Jul 31, 2004
- Completion
- Aug 31, 2004
- Last update posted
- Jan 25, 2010
2003 – 2004
United States locations
- U.S. sites
- 20
- U.S. states
- 14
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Los Angeles | California | 90027 | — |
| Not listed | Orange | California | 92868 | — |
| Not listed | San Diego | California | 92103-8376 | — |
| Not listed | Stanford | California | 94305 | — |
| Not listed | Denver | Colorado | 80218 | — |
| Not listed | Gainsville | Florida | 32610 | — |
| Not listed | Orlando | Florida | 32806 | — |
| Not listed | Boston | Massachusetts | 02114 | — |
| Not listed | Ann Arbor | Michigan | 48109-0212 | — |
| Not listed | Omaha | Nebraska | 68198-5190 | — |
| Not listed | Chapel Hill | North Carolina | 27514 | — |
| Not listed | Cleveland | Ohio | 44106 | — |
| Not listed | Columbus | Ohio | 43205-2696 | — |
| Not listed | Dayton | Ohio | 45404 | — |
| Not listed | Philadelphia | Pennsylvania | 19129 | — |
| Not listed | Charleston | South Carolina | 29425 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | Salt Lake City | Utah | 84132 | — |
| Not listed | Seattle | Washington | 98105 | — |
| Not listed | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01055847, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 25, 2010 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01055847 live on ClinicalTrials.gov.